In preclinical murine models, PD-1H has been shown to induce immune evasion, and genetic ablation or antibody blockade of PD-1H promotes T cell–mediated immunity and suppresses tumor growth (43, 48, 49, 52, 53). This evidence concerns the gene VSIR and neoplasm.